Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MilliporeSigma Offers Fully Integrated ADC Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

MilliporeSigma Offers Fully Integrated ADC Services

Designed to reduce complexity, accelerate time to market

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MilliporeSigma has begun to offer complete and fully integrated services and products for the development and manufacturing of antibody-drug conjugates (ADCs) from gene sequencing to final drug substance. Products and services include process development and manufacturing of monoclonal antibodies, linker and payload supply and conjugation expertise.

A seamless process from gene sequencing to stability testing of drug products enables customers to reduce development and manufacturing complexity, according to the company. Key benefits of the fully integrated ADC offering include: accelerated time to market; reduced supply chain complexity; streamlined development and manufacturing; and state-of-the-art technologies for manufacturing and conjugation.

While ADCs represent a promising new type of therapy, the corresponding supply chain of monoclonal antibodies, payloads and linkers presents a significant challenge. MilliporeSigma says its new combined offering provides the capabilities, products and expertise to simplify production and accelerate time to market, while managing a complex supply chain.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters